HIIFS
MNTA

Harel Insurance Investments & Financial Services’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-320
Closed -$3K – 692
2016
Q2 		$3K Sell
320
-200
-38% -$2.06K ﹤0.01% 654
2016
Q1 		$5K Hold
520
– – ﹤0.01% 417
2015
Q4 		$8K Buy
+520
New +$8.7K ﹤0.01% 304

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Harel Insurance Investments & Financial Services's MNTA Position: Q3 2016 in Review

Harel Insurance Investments & Financial Services sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2016, closing a stake of 320 shares — an estimated $3K sold.

Harel Insurance Investments & Financial Services first reported a position in MNTA in Q4 2015 and held it in 3 quarters. The position peaked at $8K in Q4 2015. 155 funds tracked by Wall St. Rank hold MNTA as of Q3 2016.

  • Harel Insurance Investments & Financial Services reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 320 Momenta Pharmaceuticals, Inc. shares in Q3 2016, an estimated $3K.
  • Harel Insurance Investments & Financial Services first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
  • Harel Insurance Investments & Financial Services's Momenta Pharmaceuticals, Inc. position peaked at $8K in Q4 2015.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2016, filed 14 Nov 2016.